Published in J Infect Dis on May 01, 1994
Prevalence of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infection among Spanish drug users measured by HTLV-1 assay and HTLV-1 and -2 assay. HTLV-1 and HTLV-2 Spanish Study Group. J Clin Microbiol (1995) 0.80
HTLV-I and HTLV-II in Africans. Genitourin Med (1995) 0.75
Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68
Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39
Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA (1985) 4.26
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA (1986) 3.05
Dental HIV transmission? Nature (1993) 2.04
The AIDS epidemic. N Engl J Med (1985) 1.82
Possible female-to-female transmission of human immunodeficiency virus. Ann Intern Med (1986) 1.82
Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study. Int J Infect Dis (1999) 1.81
Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope. J Infect Dis (1996) 1.61
Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60
Health education and knowledge assessment of HTLV-III diseases among intravenous drug users. Health Educ Q (1986) 1.58
Occurrence and distribution of serotypes of the Arizona subgroup of Salmonella strains in the United States from 1967 to 1976. J Clin Microbiol (1986) 1.55
Development and early natural history of HTLV-III antibodies in persons with hemophilia. JAMA (1985) 1.50
HTLV-I/II seroprevalence and HIV/HTLV coinfection among U.S. intravenous drug users. J Acquir Immune Defic Syndr (1991) 1.45
Interpretation of HTLV serology in case reports of new syndromes. Am J Med (1993) 1.38
HTLV-III infection among health care workers. Association with needle-stick injuries. JAMA (1985) 1.31
Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins. Clin Exp Immunol (1987) 1.30
Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin Infect Dis (1993) 1.28
Distinguishing between HTLV-I and HTLV-II by western blot. Lancet (1990) 1.27
Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Res Hum Retroviruses (1990) 1.21
Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood (1985) 1.21
HLA-DR antibodies and HTLV-III antibody ELISA testing. Lancet (1985) 1.14
Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J Infect Dis (1990) 1.12
Mycoplasma genitalium infection and host antibody immune response in patients infected by HIV, patients attending STD clinics and in healthy blood donors. FEMS Immunol Med Microbiol (1997) 1.10
Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II. Clin Diagn Virol (1996) 0.98
Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.97
Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J Infect Dis (1986) 0.96
Four-year prospective study of homosexual men: correlation of immunologic abnormalities, clinical status, and serology to human immunodeficiency virus. J Infect Dis (1987) 0.95
Lesser AIDS and tuberculosis. Lancet (1985) 0.94
Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB). AIDS Res Hum Retroviruses (1994) 0.92
Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet (1991) 0.91
Human T lymphotropic virus type I antibody patterns: evidence of difference by age and risk group. J Infect Dis (1988) 0.91
A method for predicting individual HIV infection status in the absence of clinical information. AIDS Res Hum Retroviruses (1988) 0.88
HTLV-III exposure among drug users. Cancer Res (1985) 0.86
The relationship of abnormalities of cellular immunity to antibodies to HTLV-III in homosexual men. Cell Immunol (1986) 0.86
Campylobacter enteritis associated with a healthy cat. JAMA (1982) 0.85
Comment on 'estimating the asbestos-related lung cancer burden from mesothelioma mortality' - IARC and chrysotile risks. Br J Cancer (2013) 0.83
Excretion of cytomegalovirus in semen associated with HTLV-III seropositivity in asymptomatic homosexual men. J Med Virol (1986) 0.82
Trends in HIV infection among intravenous drug users in Innsbruck, Austria. J Acquir Immune Defic Syndr (1992) 0.80
Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City. AIDS (1989) 0.80
Lymphocyte immunoregulatory cells present in semen from human immunodeficiency virus (HIV)-infected individuals: a report from the HIV Heterosexual Transmission Study. Cytometry (1996) 0.79
Evaluation of human T cell lymphotropic virus infection in a cohort of injecting drug users. J Infect Dis (1992) 0.78
Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. J Infect Dis (1995) 0.78
Partial resistance to infection by R5X4 primary HIV type 1 isolates in an exposed-uninfected individual homozygous for CCR5 32-base pair deletion. AIDS Res Hum Retroviruses (1999) 0.78
HIV-2-associated AIDS in the United States. The first case. Arch Intern Med (1989) 0.77
Epidemiology of human lymphotrophic retroviruses: an overview. Cancer Res (1985) 0.77
Amyloid nephropathy of Ostertag: report of a kindred. Birth Defects Orig Artic Ser (1974) 0.77
Serologic, immunologic, and clinical features of parenteral drug users from contrasting populations. Am J Drug Alcohol Abuse (1987) 0.76
The epidemiology of human retrovirus-associated illnesses. Mt Sinai J Med (1986) 0.75
Case for diagnosis. AIDS. Mil Med (1986) 0.75
Absence of evidence of retrovirus infection in intravenous drug users with idiopathic CD4+ lymphocytopenia. J Infect Dis (1994) 0.75
AIDS in Haitian-Americans: a reassessment. Cancer Res (1985) 0.75
Sinus histiocytosis with massive lymphadenopathy. Clin Nucl Med (1987) 0.75
Altered immunity in hemophilia correlates with the presence of antibody to human T-cell lymphotropic virus type III (HTLV-III). J Clin Immunol (1986) 0.75
Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-III. J Immunol Methods (1986) 0.75
The prevalence of HIV infection among women attending a sexually transmitted disease clinic in Birmingham, Alabama. AIDS (1989) 0.75
Idiopathic CD4+ T-lymphocytopenia. Lancet (1992) 0.75
Blood counts in male parenteral drug users. JAMA (1985) 0.75
Spontaneous lymphocyte proliferation in HTLV-II infection. Lancet (1991) 0.75